<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03994614</url>
  </required_header>
  <id_info>
    <org_study_id>JIAI 2019-4</org_study_id>
    <nct_id>NCT03994614</nct_id>
  </id_info>
  <brief_title>the Effect of Acupuncture on the Quality of Oocyte on Poor Ovarian Response(POR)</brief_title>
  <acronym>POR</acronym>
  <official_title>The Clinical Trial of the Effect of Acupuncture on the Quality of the Oocyte on Poor Ovarian Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ShangHai Ji Ai Genetics &amp; IVF Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ShangHai Ji Ai Genetics &amp; IVF Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients in experimental group will be given acupuncture treatment for 12 weeks prior to
      controlled ovarian stimulation (COS).The patients will be given three times acupuncture every
      week except menstruation.Patients in no intervention group will not be given any intervention
      for 12 weeks prior to COS. The primary outcome measure is the number of MII eggs obtained in
      the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients will be randomly recruited into two groups. Patients in experimental group will
      be given acupuncture treatment for 12 weeks prior to COS.The patients will be given three
      times acupuncture every week except menstruation. One treatment lasts for 30 minutes. The
      acupuncture acupoint locations are as follows: head acupoint(Yintang, Shenting, Baihui),
      abdominal acupoint (Guanyuan, Zhongji), leg acupoint(Sanyinjiao, Zusanli),waist acupoint
      (Shenyu, Guanyuanyu）. Patients in no intervention group will not be given any intervention
      for 12 weeks prior to COS.

      When at least one dominant follicle is greater than 18 mm then injection Human chorionic
      gonadotropin （hCG） 10000 IU. 36 hours later transvaginal oocyte retrieval will be taken.
      After 3 hours of incubation, each egg will be transferred with a density of about
      100,000/mllive sperm. The fresh embryo transfer is performed 72 hours after embryo culture in
      vitro. The whole embryos will be frozen.

      The primary outcome measure is the number of MII eggs obtained in the COS cycle. The
      secondary outcome measures are the lab and clinical reproductive outcomes,including basic
      endocrine, serum Anti-Mullerian Hormone （AMH）, gonadotropin （Gn） dosage and duration,
      estrogen level on HCG day, number of eggs obtained, fertilization rate, cleavage rate,
      effective embryo rate, cycle cancellation rate, the clinical pregnancy rate.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of MII eggs</measure>
    <time_frame>one day after oocyte pickup</time_frame>
    <description>The number of MII eggs obtained in the COS cycle</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Basic Follicle stimulating hormone （FSH） value</measure>
    <time_frame>On Day two of menstruation</time_frame>
    <description>Basic FSH value in mIU/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic Luteinizing hormone （LH） value</measure>
    <time_frame>On Day two of menstruation</time_frame>
    <description>Basic LH in mIU/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic estrodiol value</measure>
    <time_frame>On Day two of menstruation</time_frame>
    <description>Basic estrodiol in pg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum AMH value</measure>
    <time_frame>On Day two of menstruation</time_frame>
    <description>Serum AMH in ng/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>estrogen level</measure>
    <time_frame>estrogen level on HCG day</time_frame>
    <description>estrogen level on HCG day in pg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of embryo</measure>
    <time_frame>On the day 5-6 after oocyte pickup</time_frame>
    <description>the number of embryo obtained in the COS cycle</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Poor Ovarian Response</condition>
  <arm_group>
    <arm_group_label>the Acupuncture intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be given acupuncture treatment for 12 weeks prior to COS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will not be given any intervention for 12 weeks prior to COS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>acupuncture</intervention_name>
    <description>Patients in the experimental group will be given acupuncture treatment for 12 weeks prior to COS. The patients will be given three times acupuncture every week except menstruation. The acupuncture acupoint locations are as follows: head acupoint(Yintang, Shenting, Baihui), abdominal acupoint (Guanyuan, Zhongji), leg acupoint(Sanyinjiao, Zusanli),waist acupoint (Shenyu, Guanyuanyu）</description>
    <arm_group_label>the Acupuncture intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The poor ovarian response patients compliance with Bologna consensus

          2. Age：20-45 year

        Exclusion Criteria:

          1. Her husband is oligoasthenospermia

          2. Patients with genital tract malformation. Uterine malformation (single uterus, double
             uterus, double uterus, untreated mediastinal uterus) and other effects affecting
             uterine cavity disease (adenomyosis, submucosal uterine fibroids, intrauterine
             adhesions and scar uterus)

          3. Complicated with medical diseases（Hypertension, diabetes, psychosis, hereditary
             diseases）

          4. Refusal to sign the informed consent form
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wenbi Zhang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wenbi Zhang, doctor</last_name>
    <phone>+8618616860905</phone>
    <email>jackeyzhang0905@163.com</email>
  </overall_contact>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 2, 2019</study_first_submitted>
  <study_first_submitted_qc>June 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2019</study_first_posted>
  <last_update_submitted>July 4, 2019</last_update_submitted>
  <last_update_submitted_qc>July 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>quality</keyword>
  <keyword>oocyte</keyword>
  <keyword>poor ovarian response</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

